![Oliver Cumming](https://profiles-cardiff.imgix.net/attachments/665?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Overview
I am a Research Assistant within the CTR. Working with different teams to facilitate accurate and efficient data collection and reporting.
Publication
2023
- Russell, N. et al. 2023. P484: Gemtuzumab-based induction chemotherapy combined with midostaurin for FLT3 mutated AML. Updated toxicity and interim survival analysis from the NCRI AML19v2 "Midotarg" Pilot Trial. HemaSphere 7(S3), article number: e13145db. (10.1097/01.HS9.0000968844.13145.db)
Erthyglau
- Russell, N. et al. 2023. P484: Gemtuzumab-based induction chemotherapy combined with midostaurin for FLT3 mutated AML. Updated toxicity and interim survival analysis from the NCRI AML19v2 "Midotarg" Pilot Trial. HemaSphere 7(S3), article number: e13145db. (10.1097/01.HS9.0000968844.13145.db)
Engagement
Contact Details
CummingO1@cardiff.ac.uk
+44 29225 11688
Neuadd Meirionnydd, Floor 5, University Hospital of Wales, Heath Park, Cardiff, CF14 4YS
+44 29225 11688
Neuadd Meirionnydd, Floor 5, University Hospital of Wales, Heath Park, Cardiff, CF14 4YS
Research themes
Specialisms
- Database systems
- Surveys, questionnaires and quantitative data collection
- Clinical Trials